Damian Dudek

Dr. Damian Dudek

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010
Verified
Book Chapter
Closed access
PDF file
DDDamian Dudek
Damian Dudek

15 December 2009 in Information Sciences
Verified
Journal Article
Closed access
DDDamian Dudek
Damian Dudek

ŁSŁucja Sobkowska
Łucja Sobkowska
JSJulia Sobkowska
Julia Sobkowska
DDDamian Dudek
Damian Dudek
BGBENIAMIN Oskar GRABAREK
BENIAMIN Oskar GRABAREK
ACAgata Czajka-Jakubowska
Agata Czajka-Jakubowska
APAgnieszka Przystańska
Agnieszka Przystańska
This prospective study examined a population of 520 urban and rural children aged 5 to 9 years. Every 2–4 weeks, the clinical symptoms accompanying primary tooth replacement such as a cough, a runny nose, pain, and body temperature were assessed in each child’s medical records. The authors were able to show in a statistically significant manner that the frequency, time, and type of cough were strongly related to the type of erupting teeth (p < 0.001 for each relationship). A cough dependent on the type of erupting teeth was observed in 86% to 92% of the examined children, with a morning bronchial cough being connected with an eruption of the lower teeth, and an eruption of the upper teeth producing an all-day pharyngeal cough caused by mucus secretions dripping down the back of the throat. A statistically significant relationship was also confirmed between the type of erupting teeth and the incidence of a runny nose (p < 0.001), the frequency of a runny nose (p < 0.001), and the time when runny nose symptoms occurred (p < 0.001). This study shows that the period when primary dentition is replaced with permanent teeth in children is characterized by a physiological cough and a runny nose.

18 May 2021 in Folia Histochemica et Cytobiologica
Verified
Journal Article
Open access
PDF file
EREdyta Reichmann-Warmusz
Edyta Reichmann-Warmusz
MBMarlena Brzozowa-Zasada
Marlena Brzozowa-Zasada
CWCelina Wojciechowska
Celina Wojciechowska
DDDamian Dudek
Damian Dudek
OWOliwia Warmusz
Oliwia Warmusz
RWRomuald Wojnicz
Romuald Wojnicz
Introduction. Endothelial dysfunction is a critical part of heart failure (HF) pathophysiology. It is not clear, however, whether it is present at the similar level in the early and late HF stages. Material and methods. von Willebrand factor (vWF) and its mRNA levels in biopsies of non-ischemic patients with HF secondary to dilated cardiomyopathy were studied. Consecutive patients with HF were divided into two groups: group A with disease duration ≤ 12 months (n = 59) and group B with disease duration > 12 months (n = 68). The immunoreactivity of the vWF was compared with autopsy sections of 19 control cases. Tissue vWF gene expression was analyzed at the mRNA level by RT-PCR. Results. In the group A, there was lower vWF immunoreactivity in the coronary microvessels compared to the group B [1.5 (1.0–2.0) vs. 2.0 (1.5–2.4), P = 0.001]. In the control group, only weak vWF expression was observed. Protein expression was not accompanied by vWF mRNA whose levels were significantly higher in the Group A as compared to the Group B [14671 (4932-51561) vs. 3643 (185.3–9030.8), P = 0.005]. Protein vWF expression was inversely associated with its mRNA levels (r = –0.34, P = 0.04). Conclusions. High myocardial protein expression of vWF in patients with long-lasting HF symptoms may highlight the persistent nature of endothelial dysfunction in such a cohort of patients. Introduction. Endothelial dysfunction is a critical part of heart failure (HF) pathophysiology. It is not clear, however, whether it is present at the similar level in the early and late HF stages. Material and methods. von Willebrand factor (vWF) and its mRNA levels in biopsies of non-ischemic patients with HF secondary to dilated cardiomyopathy were studied. Consecutive patients with HF were divided into two groups: group A with disease duration ≤ 12 months (n = 59) and group B with disease duration > 12 months (n = 68). The immunoreactivity of the vWF was compared with autopsy sections of 19 control cases. Tissue vWF gene expression was analyzed at the mRNA level by RT-PCR. Results. In the group A, there was lower vWF immunoreactivity in the coronary microvessels compared to the group B [1.5 (1.0–2.0) vs. 2.0 (1.5–2.4), P = 0.001]. In the control group, only weak vWF expression was observed. Protein expression was not accompanied by vWF mRNA whose levels were significantly higher in the Group A as compared to the Group B [14671 (4932-51561) vs. 3643 (185.3–9030.8), P = 0.005]. Protein vWF expression was inversely associated with its mRNA levels (r = –0.34, P = 0.04). Conclusions. High myocardial protein expression of vWF in patients with long-lasting HF symptoms may highlight the persistent nature of endothelial dysfunction in such a cohort of patients.